Latest Breaking News On - University of tennessee college medicine - Page 3 : comparemela.com

FDA Approves Erosive GERD Therapy Vonoprazan

Phathom Pharmaceuticals' vonoprazan (Voquenza) sets a new standard in erosive gastroesophageal reflux disease (GERD) therapy.

FDA OKs New Treatment for Erosive Esophagitis

Vonoprazan (Voquezna) is indicated for the healing and maintenance of healing of all grades of erosive esophagitis, as well as relief of associated heartburn in adults.

Phathom Pharmaceuticals' erosive esophagitis treatment approved by FDA

The US Food and Drug Administration (FDA) has approved a potassium-competitive acid blocker (PCAB) as a new treatment for the healing of all grades of erosive esophagitis.

Voquezna back on track with FDA approval for erosive esophagitis, heartburn relief

FDA Approves Vonoprazan for Erosive GERD

The approval marks the first major innovation in the United States for the treatment of erosive GERD in over 30 years.